AC
CDMO

AlphaCore Capital’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

AlphaCore Capital’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-12,000
Closed -$138K – 65
2020
Q4 		$138K Buy
+12,000
New +$110K 0.1% 35

Other funds holding CDMO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ICM
ISZO Capital Management New York $2M AUM 35.61% 1-Year Est. Return
AC
AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

AlphaCore Capital's CDMO Position: Q1 2021 in Review

AlphaCore Capital sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2021, closing a stake of 12,000 shares — an estimated $138K sold.

AlphaCore Capital first reported a position in CDMO in Q4 2020 and held it in 1 quarter. The position peaked at $138K in Q4 2020. 158 funds tracked by Wall St. Rank hold CDMO as of Q1 2021.

  • AlphaCore Capital reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • AlphaCore Capital sold 12,000 Avid Bioservices, Inc. Common Stock shares in Q1 2021, an estimated $138K.
  • AlphaCore Capital first reported a position in Avid Bioservices, Inc. Common Stock in Q4 2020 and held it in 1 quarter.
  • AlphaCore Capital's Avid Bioservices, Inc. Common Stock position peaked at $138K in Q4 2020.
  • 158 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2021.

Based on AlphaCore Capital's 13F filing for Q1 2021, filed 10 May 2021.